Results 1 to 10 of about 82,188 (247)

A Comparison of Myopia Control in European Children and Adolescents With Defocus Incorporated Multiple Segments (DIMS) Spectacles, Atropine, and Combined DIMS/Atropine [PDF]

PLoS ONE, 2023
PurposeTo evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the progression of myopia in a population of European children in comparison with 0.01% atropine and combined DIMS and atropine.MethodsThe study was a non-randomised ...
Andrea Lembo, Paolo Nucci, Rakhee Shah
exaly   +4 more sources

Efficacy of Atropine, Orthokeratology, and Combined Atropine With Orthokeratology for Childhood Myopia: A Systematic Review and Network Meta-Analysis

Journal of the Formosan Medical Association, 2022
Background/Purpose: Orthokeratology (Ortho-K), atropine eye drops and combined atropine with Ortho-K are proven to be effective ways to prevent myopic progression in many studies, but there is scarce evidence regarding the comparative efficacy of ...
Cheng-Jen Chiu, Jen-Hung Wang, Tai-Li Chen   +2 more
exaly   +3 more sources

Stepwise Increase in Concentrations of Atropine Treatment for Myopia Control Study [PDF]

Ophthalmology Science
Purpose: To explore a stepwise atropine treatment strategy for myopic control: beginning with 0.01% atropine for 6 months, followed by adjustment to higher concentrations based on treatment response. Design: Prospective study.
Shifei Wei, PhD, Wenzai An, PhD, Yunyun Sun, PhD, Xintong Liang, PhD, Weiling Bai, MD, Zhining Cai, MD, Shengjun Zhao, MD, Shi-Ming Li, PhD, Ningli Wang, PhD   +8 more
doaj   +2 more sources

The Effect of Low-Dose Atropine on Alpha Ganglion Cell Signaling in the Mouse Retina

Frontiers in Cellular Neuroscience, 2021
Low-dose atropine helps to control myopia progression with few side effects. However, the impact of atropine, a non-selective muscarinic Acetylcholine (ACh) receptor antagonist, on retinal ganglion cells (RGCs) remains unclear. After immersing the cornea
Qin Wang, Seema Banerjee, ChungHim So, ChunTing Qiu, YingHon Sze, Thomas Chuen Lam, Thomas Chuen Lam, Chi-Ho To, Chi-Ho To, Feng Pan, Feng Pan   +10 more
doaj   +1 more source

Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis

Frontiers in Medicine, 2022
Purpose: To evaluate the efficacy and safety of atropine for slowing myopia progression and to investigate whether the treatment effect remains constant with continuing treatment.Method: Studies were retrieved from MEDLINE, EMBASE, and the Cochrane ...
Jiahe Gan, Jiahe Gan, Shi-Ming Li, Shi-Ming Li, Shanshan Wu, Kai Cao, Kai Cao, Dandan Ma, Dandan Ma, Xi He, Xi He, Ziyu Hua, Ziyu Hua, Meng-Tian Kang, Meng-Tian Kang, Shifei Wei, Shifei Wei, Weiling Bai, Weiling Bai, Ningli Wang, Ningli Wang   +20 more
doaj   +1 more source

Stability and Sterility of Extemporaneously Prepared 0.01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution

Siriraj Medical Journal, 2022
Objective: The aim of this study was to investigate the physicochemical and microbiological stability of extemporaneously prepared 0.01% atropine ophthalmic solution in unopened eyedropper and in simulated use condition.
Jureeporn Sri-in, Waraphorn Sisan, Phonphailin Kingkhangphloo, Pinpilai Jutasompakorn, Weerawadee Chandranipapongse, Somruedee Chatsiricharoenkul, Onchira Buranakan, Arpha Pornseth, Thammanoon Surachatkumtonekul   +8 more
doaj   +1 more source

0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial [PDF]

International Journal of Ophthalmology, 2023
AIM: To evaluate the effect of 0.05% atropine on the control of myopia for 2y (phase I) and on spherical equivalent refraction (SER) progression for 1y (phase II) after its withdrawal in Chinese myopic children.
Qin Zhu, Guang-Yong Tang, Zhi-Juan Hua, Li-Ping Xue, Yuan Zhou, Jie-Ying Zhang, Ying-Ting Zhu, Xiao-Fan Zhang   +7 more
doaj   +1 more source

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants

BMC Research Notes, 2022
Objective As low-dose atropine eye-drops for myopia progression control prepared in-house by diluting the commercial 0.1% atropine eye-drop with sterile water or normal saline has been a common practice whereas atropine injection is readily available and
Nuthida Wongwirawat, Nirachorn Kuchonthara, Sorrawit Boontanomwong, Krit Pongpirul   +3 more
doaj   +1 more source

Treatment of 0.01% atropine eye drops induced convergence excess esotropia and rebound myopia managed with 1% atropine eye drops

Indian Journal of Ophthalmology. Case Reports, 2021
We report a case of progressive childhood myopia who developed rebound myopia and convergence excess esotropia after switching from 1% atropine eye drops to 0.01% atropine eye drops.
Shairin Jahan, Mihir Kothari, Meghna Solanki   +2 more
doaj   +1 more source

Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility

BMC Veterinary Research, 2021
Background Topical ophthalmic atropine sulfate is an important part of the treatment protocol in equine uveitis. Frequent administration of topical atropine may cause decreased intestinal motility and colic in horses due to systemic exposure.
L. Ström, F. Dalin, M. Domberg, C. Stenlund, U. Bondesson, M. Hedeland, P-L Toutain, C. Ekstrand   +7 more
doaj   +1 more source